Electrical Explosion Proof Equipment Strategic Industry Research 2024-2030: Rising Awareness of Safety Standards, Geographic Expansion of Mining and Chemical Industries Bolsters Demand
September 20, 2024 07:07 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Electrical Explosion Proof Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
September 19, 2024 02:30 ET
|
Virtual Investor Conferences
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday, September 24 and Wednesday,...
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
September 17, 2024 20:00 ET
|
Virtual Investor Conferences
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday, September 24 and Wednesday,...
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
September 17, 2024 11:22 ET
|
Virtual Investor Conferences
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday, September 24 and Wednesday,...
Atenolol Market Report 2024: Growing Demand for Beta-1 Selective Blockers, Regulatory Approvals for New Formulations and Rising Demand for Combination Therapies in Treating Cardiovascular Conditions
September 17, 2024 08:59 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Atenolol Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The atenolol market size has grown strongly in recent years,...
Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
September 11, 2024 06:30 ET
|
Arch Biopartners
TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that Alberta Health Services (AHS) has approved the...
Adult Vaccine Market Forecasts Report and Competitive Landscape 2024-2032 Featuring GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, and CSL
September 10, 2024 07:12 ET
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Adult Vaccine Market Report, Forecast by Disease, Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's...
$12.5 Bn Influenza Vaccine Market to 2032 by Vaccine Type, Technology, Age Group, Route of Administration, and Region
September 09, 2024 10:00 ET
|
Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Influenza Vaccine Market Report by Vaccine Type, Technology, Age Group, Route of Administration, and Region 2024-2032" report has been added to ...
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors - Global Strategic Business Report 2024-2030, with Coverage of Akeso, Alphamab Oncology, BioAtla, BioNTech, Sino Biological and Xencor
September 04, 2024 09:41 ET
|
Research and Markets
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors - Global Strategic Business Report" has been added to ResearchAndMarkets.com's...
Precision Medicine Market Report 2024: Comprehensive Data on Products, Technologies, Applications, End Users, Countries and Companies, 2024-2032, Featuring AstraZeneca, Bayer, bioMerieux, and More
September 02, 2024 09:41 ET
|
Research and Markets
Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Market Report, Forecast by Product, Technology, Application, End User, Countries and Company Analysis, 2024-2032" report has been...